Back

CDK4/6 inhibitor ribociclib induces cardiotoxicity in dynamic engineered heart tissues, mitigated by E2F1 overexpression

12 April 2024 (08:30 - 14:00)
Organised by: Logo
Congress Presentation Part of: The immune system in the pathogenesis and treatment of cancer therapy-induced cardiovascular toxicity Stem Cells, Cell Cycle, Cell Senescence, Cell Death CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Mr Itamar Dias

University Medical Centre Groningen, Groningen (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Cardioprotection via modulation of the immune response
Doctor Z. Varga (Budapest, HU)
Slides
Presentation thumbnail
Cancer therapies and vascular toxicities
Professor I. Andreadou (Athens, GR)
Slides
Presentation thumbnail
Accelerated atherosclerosis by immune checkpoint inhibitors
Doctor N. Van Es (Amsterdam, NL)
Slides

Access the full session

Session thumbnail
The immune system in the pathogenesis and treatment of cancer therapy-induced cardiovascular toxicity

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources